MCID: CTN003
MIFTS: 50

Cutaneous Lupus Erythematosus malady

Categories: Rare diseases, Immune diseases, Skin diseases

Aliases & Classifications for Cutaneous Lupus Erythematosus

About this section

Aliases & Descriptions for Cutaneous Lupus Erythematosus:

Name: Cutaneous Lupus Erythematosus 11 48 13
Lupus Erythematosus, Cutaneous 48 68
 
Lupus Erythematosus Cutaneous 50

Classifications:



External Ids:

Disease Ontology11 DOID:0050169

Summaries for Cutaneous Lupus Erythematosus

About this section
Disease Ontology:11 A lupus erythematosus that causes skin lesions on parts of the body that are exposed to sunlight.

MalaCards based summary: Cutaneous Lupus Erythematosus, also known as lupus erythematosus, cutaneous, is related to angioedema and rheumatoid arthritis, and has symptoms including dry skin, hyperkeratosis and edema. An important gene associated with Cutaneous Lupus Erythematosus is CXCR3 (C-X-C Motif Chemokine Receptor 3), and among its related pathways are Cellular roles of Anthrax toxin and Immune response_MIF-mediated glucocorticoid regulation. Affiliated tissues include skin, t cells and neutrophil, and related mouse phenotypes are Synthetic lethal with MLN4924 (a NAE inhibitor) and cardiovascular system.

Related Diseases for Cutaneous Lupus Erythematosus

About this section

Diseases in the Cutaneous Lupus Erythematosus family:

Subacute Cutaneous Lupus Erythematosus

Diseases related to Cutaneous Lupus Erythematosus via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 191)
idRelated DiseaseScoreTop Affiliating Genes
1angioedema30.0ICAM1, TNF
2rheumatoid arthritis28.9CD40LG, ICAM1, IL18, TNF
3systemic lupus erythematosus27.2CD40LG, CXCR3, ICAM1, IL18, TNF, TREX1
4subacute cutaneous lupus erythematosus12.6
5lupus erythematosus11.1
6atypical depressive disorder10.6MX1, TNF
7steatorrhea10.6IL18, TNF
8qualitative platelet defect10.5IL18, TNF
9sterility due to immotile flagella10.5IL18, TNF
10primary orthostatic tremor10.5CXCR3, TNF
11hernia of ovary and fallopian tube10.5CXCR3, TNF
12renal cell carcinoma 410.5IL18, TNF
13mastocytosis cutaneous with short stature conductive hearing loss and microtia10.4MX1, TNF
14gonococcal synovitis10.4SELE, TNF
15endocarditis10.4TNF, TRIM21
16oral candidiasis10.3IL18, TNF
17vibrio vulnificus infection10.3CXCR3, ICAM1
18arteriolosclerosis10.3ICAM1, IL18
19meninges hemangiopericytoma10.3ICAM1, TNF
20hepatitis e10.3ICAM1, TRIM21
21atrichia with papular lesions10.3ICAM1, TNF
22lymphomatoid papulosis10.2ICAM1, SELE
23marginal corneal ulcer10.2ICAM1, SELE
24endocardium disease10.2TRIM21, TROVE2
25peripheral scars of retina10.2ICAM1, SELE
26pulmonary nodular lymphoid hyperplasia, familial10.2TRIM21, TROVE2
27toxic maculopathy10.2ICAM1, MX1, TNF
28kernicterus10.2ICAM1, MX1, TNF
29posterolateral myocardial infarction10.2ICAM1, SELE
30diamond-blackfan anemia 310.2CXCR3, IL18, TNF
31cysticercosis10.2ICAM1, SELE
32ampulla of vater neoplasm10.2SELE, TNF
33penis basal cell carcinoma10.2CD40LG, MX1
34night blindness10.2CD40LG, TNF
35retinal perforation10.2CD40LG, MX1
36intraneural perineurioma10.2ICAM1, SELE
37brucella abortus brucellosis10.2CD40LG, TNF
38ornithosis10.2CD40LG, EEA1
39temporal arteritis10.1CD40LG, MX1
40ileocolitis10.1CD40LG, TNF
41developmental coordination disorder10.1ICAM1, SELE
42spotted fever10.1CD40LG, EEA1
43scleral disease10.1CD40LG, TNF
44bolivian hemorrhagic fever10.1CXCR3, ICAM1, TNF
45non-secretory myeloma10.1CD40LG, TNF
46visual pathway disease10.1CD40LG, IL18
47occlusion of gallbladder10.1CD40LG, KRT15
48suppurative uveitis10.1CD40LG, TNF
49chromophobe adenoma10.1ICAM1, SELE
50dermatomyositis10.1

Graphical network of the top 20 diseases related to Cutaneous Lupus Erythematosus:



Diseases related to cutaneous lupus erythematosus

Symptoms & Phenotypes for Cutaneous Lupus Erythematosus

About this section

Human phenotypes related to Cutaneous Lupus Erythematosus:

 64 (show all 14)
id Description HPO Frequency HPO Source Accession
1 dry skin64 hallmark (90%) HP:0000958
2 hyperkeratosis64 hallmark (90%) HP:0000962
3 edema64 hallmark (90%) HP:0000969
4 skin rash64 hallmark (90%) HP:0000988
5 pruritus64 hallmark (90%) HP:0000989
6 hypermelanotic macule64 hallmark (90%) HP:0001034
7 acrocyanosis64 hallmark (90%) HP:0001063
8 arthralgia64 hallmark (90%) HP:0002829
9 psoriasis64 hallmark (90%) HP:0003765
10 abnormal blistering of the skin64 hallmark (90%) HP:0008066
11 telangiectasia of the skin64 hallmark (90%) HP:0100585
12 skin ulcer64 hallmark (90%) HP:0200042
13 cutaneous photosensitivity64 occasional (7.5%) HP:0000992
14 verrucae64 occasional (7.5%) HP:0200043

UMLS symptoms related to Cutaneous Lupus Erythematosus:


exanthema, pruritus, skin manifestations

GenomeRNAi Phenotypes related to Cutaneous Lupus Erythematosus according to GeneCards Suite gene sharing:

26
idDescriptionGenomeRNAi Source AccessionScoreTop Affiliating Genes
1GR00250-A-18.1CD40LG, ICAM1, IL18, MX1, TNF

MGI Mouse Phenotypes related to Cutaneous Lupus Erythematosus according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053858.4CD40LG, CXCR3, ICAM1, IL18, SELE, TNF
2MP:00107718.0CD40LG, ICAM1, IL18, SELE, TNF, TREX1
3MP:00053977.8CD40LG, CXCR3, ICAM1, IL18, SELE, TNF
4MP:00053877.7CD40LG, CXCR3, ICAM1, IL18, SELE, TNF
5MP:00107687.7CD40LG, CXCR3, ICAM1, IL18, SELE, TNF

Drugs & Therapeutics for Cutaneous Lupus Erythematosus

About this section

Drugs for Cutaneous Lupus Erythematosus (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 119)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1HormonesPhase 413979
2Hormone AntagonistsPhase 412778
3Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 412767
4Melanocyte-Stimulating HormonesPhase 4132
5Adrenocorticotropic HormonePhase 4155
6beta-endorphinPhase 4133
7Omega 3 Fatty AcidNutraceuticalPhase 4969
8
HydroxychloroquineapprovedPhase 3146118-42-33652
Synonyms:
(+-)-Hydroxychloroquine
(±)-hydroxychloroquine
118-42-3
2-((4-((7-Chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol
2-((4-((7-chloro-4-Quinolyl)amino)pentyl)ethylamino)ethanol
2-(N-(4-(7-Chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol
2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol
2-[{4-[(7-chloroquinolin-4-yl)amino]pentyl}(ethyl)amino]ethanol
5-22-10-00280 (Beilstein Handbook Reference)
7-Chloro-4-(4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline
7-Chloro-4-(4-(ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline
7-Chloro-4-(5-(N-ethyl-N-2-hydroxyethylamino)-2-pentyl)aminoquinoline
7-chloro-4-(4-(Ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline
7-chloro-4-(4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline
7-chloro-4-[4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino]quinoline
7-chloro-4-[5-(N-Ethyl-N-2-hydroxyethylamino)-2-pentyl]aminoquinoline
747-36-4 (sulfate (1:1) salt)
AC1L1GEW
BRN 0253894
C07043
C18H26ClN3O
CHEMBL1535
CID3652
D08050
DB01611
DivK1c_000942
EINECS 204-249-8
Gen-Hydroxychloroquine 200mg Tablets
HCQ
HMS502P04
Hidroxicloroquina
 
Hidroxicloroquina [INN-Spanish]
Hydroxychlorochin
Hydroxychloroguine
Hydroxychloroquine (INN)
Hydroxychloroquine Sulfate (1:1) Salt
Hydroxychloroquine [INN:BAN]
Hydroxychloroquinum
Hydroxychloroquinum [INN-Latin]
IDI1_000942
Idrossiclorochina
Idrossiclorochina [DCIT]
KBio1_000942
LS-66614
MolPort-003-847-792
NCGC00159483-02
NINDS_000942
NSC4375
Oxichlorochine
Oxichlorochinum
Oxichloroquine
Oxychlorochin
Oxychloroquine
PlaqueN/A
Polirreumin
Polirreumin (TN)
Quensyl
SPBio_001116
ST072188
Spectrum2_001238
Spectrum5_001697
UNII-4QWG6N8QKH
WIN 1258
hydroxychloroquine
9Protective AgentsPhase 37190
10Antirheumatic AgentsPhase 3, Phase 2, Phase 110627
11Dermatologic AgentsPhase 3, Phase 25674
12Anti-Infective AgentsPhase 3, Phase 221402
13Antiprotozoal AgentsPhase 31986
14Radiation-Protective AgentsPhase 3466
15Sunscreening AgentsPhase 3113
16Antiparasitic AgentsPhase 32127
17AntimalarialsPhase 31216
18
Etanerceptapproved, investigationalPhase 2397185243-69-0
Synonyms:
185243-69-0
CD120b
D00742
Enbrel
Enbrel (TN)
Enbrel Sureclick
Etanercept
Etanercept (USAN/INN)
 
Etanercept (genetical recombination)
Etanercept (genetical recombination) (JAN)
TNF-R2
Tumor necrosis factor receptor 2
Tumor necrosis factor receptor superfamily member 1B precursor
Tumor necrosis factor receptor type II
etanercept
p75
p80 TNF-alpha receptor
19
Tacrolimusapproved, investigationalPhase 21074104987-11-3445643, 439492
Synonyms:
(-)-FK 506
(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone
104987-11-3
109581-93-3 (Hydrate)
15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone,
3S-[3R*[E(1S*,3S*,4S*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5, 19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido[2,1-c] [1,4] oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone
8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN
AC-1182
AC1L1K7H
AC1L97GB
AC1L9IBU
AKOS005145901
Advagraf
Ambap104987-11-3
Ambap5429
Anhydrous tacrolimus
BCBcMAP01_000194
BRD-K35452788-001-02-1
BSPBio-001279
BSPBio_001279
Bio-0921
Bio2_000470
Bio2_000950
C01375
C44H69NO10
CCRIS 7124
CHEBI:100924
CHEBI:61049
CHEMBL1200738
CID11158639
CID11556866
CID439492
CID445643
CID5372
CID5472317
CID6426916
CID6436007
CID6473866
CID6536850
CID6610362
CID6912836
CID9832283
CID9853905
CID9918805
CID9940643
CID9963169
CPD-10016
CPD000466356
D08556
DB00864
DivK1c_001040
FK 506
FK-506
FK5
FK506
FR 900506
FR-900506
 
FR900506
FT-0082660
Fk-506
Fujimycin
Graceptor
HMS1362O21
HMS1792O21
HMS1990O21
HMS2051C18
HMS2093M19
HMS503O21
IDI1_001040
IDI1_002225
K506
KBio1_001040
KBio2_000619
KBio2_003187
KBio2_005755
KBio3_001097
KBio3_001098
KBioGR_000619
KBioSS_000619
L 679934
L-679934
LCP-Tacro
LMPK04000003
LS-64247
MLS000759471
MLS001424054
Modigraf
MolPort-003-666-518
NCGC00163470-01
NCGC00163470-02
NCGC00163470-03
NCGC00163470-04
NCGC00179232-01
NChemBio.2007.16-comp1
NINDS_001040
NSC717865
Prograf
Prograf (TN)
Protopic
Protopy
S5003_Selleck
SAM001246677
SMR000466356
Tacarolimus
Tacrolimus (INN)
Tacrolimus (Prograf?)
Tacrolimus (anhydrous)
Tacrolimus anhydrous
Tacrolimus hydrate
Tacrolimus, anhydrous
Tsukubaenolide
UNII-Y5L2157C4J
nchembio.2007.23-comp2
tacrolimus
tacrolimus hydrate
20
Apremilastapproved, investigationalPhase 1, Phase 264608141-41-911561674
Synonyms:
Apremilast
Apremilast (USAN)
Apremilastum
Aprémilast
CC-10004
 
CHEBI:558773
CHEMBL514800
CID11561674
D08860
N-[2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methylsulfonyl-ethyl]-1,3-dioxo-isoindol-4-yl]acetamide
N-{2-[(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide
21
belimumabapprovedPhase 246356547-88-15957, 10451420
Synonyms:
356547-88-1
Belimumab
Belimumab (USAN)
 
Benlysta
D03068
LymphoStat-B
LymphoStat-B (TN)
belimumab
22
Dimethyl fumarateapproved, investigationalPhase 281624-49-75271565, 637568
Synonyms:
(E)-CH3OC(O)CH=CHC(O)OCH3
(e)-But-2-enedioic acid dimethyl ester
1,2-Bis(methoxycarbonyl)-trans-Ethylene
1,2-Bis(methoxycarbonyl)-trans-ethylene
2-Butenedioic acid (2E)-, 1,4-dimethyl ester
2-Butenedioic acid (2E)-, dimethyl ester
2-Butenedioic acid (E)-, dimethyl ester
2-Butenedioic acid, dimethyl ester
Allomaleic acid dimethyl ester
BG 12 compound
BG-12
Boletic acid dimethyl ester
But-2-enedioic acid, dimethyl ester
Dimethyl (2E)-2-butenedioate
Dimethyl (2E)-but-2-enedioate
Dimethyl (E)-but-2-enedioate
Dimethyl but-2-enedioate
Dimethyl ester(2E)-2-Butenedioic acid
 
Dimethyl ester(E)-2-Butenedioic acid
Dimethyl fumarate
Dimethyl fumarate (usan)
Dimethyl trans-ethylenedicarboxylate
Dimethylester kyseliny fumarove
Dimethylfumarate
Fumaderm
Fumaric acid dimethyl ester
Fumaric acid, dimethyl ester
Fumaric acid, dimethyl ester (8CI)
Maleic acid, dimethyl ester
Methyl fumarate
Tecfidera
Trans-butenedioic acid dimethyl ester
dimethyl (E) butenedioate
trans-1, 2-Ethylenedicarboxylic acid dimethyl ester
trans-1,2-Ethylenedicarboxylic Acid dimethyl ester
trans-1,2-Ethylenedicarboxylic acid dimethyl ester
trans-Butenedioic acid dimethyl ester
23
Mycophenolate mofetilapproved, investigationalPhase 2939128794-94-55281078
Synonyms:
115007-34-6
128794-94-5
140401-05-4
2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate
2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate
4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl -3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E)
AC-1562
AC1NQXZW
AC1Q6O6X
AR-1J6939
BB_NC-2566
C07908
C23H31NO7
CHEMBL1456
CID5281078
CellCept
CellCept, RS 61443, TM-MMF, Mycophenolate mofetil
Cellcept
Cellcept (TN)
D00752
DB00688
HMS2090A03
 
HSDB 7436
I01-0898
I06-1947
LS-172272
LS-75572
ME-MPA
MMF
MMF CellCept(TM)
MolPort-000-883-800
Munoloc
Mycophenolate mofetil (JAN/USAN)
Mycophenolic acid morpholinoethyl ester
Mycophenylate mofetil
NCGC00159459-02
NCGC00159459-03
NSC724229
R-99
RS 61443
RS-61443
RS-61443-190
S1501_Selleck
TL8000648
TM-MMF
UNII-9242ECW6R0
ZINC21297660
mycophenolate mofetil
24
Mycophenolic acidapprovedPhase 293924280-93-1446541
Synonyms:
(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid
Acide mycophenolique
Acido micofenolico
Acidum mycophenolicum
 
Melbex
Micofenolico acido
Mycophenoic acid
Mycophenolate
Mycophenolsäure
Myfortic
25
Alitretinoinapproved, investigationalPhase 2155300-03-8444795
Synonyms:
(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
(7e,9Z,11e,13e)-Retinoic acid
(9cis)-retinoic acid
.beta.-Retinoic acid
187175-63-9
1n4h
302-79-4
5300-03-8
56573-65-0
7005-78-9
9 Cis Retinoic Acid
9(Z)-Retinoic acid
9-CIS-RETINOIC ACID
9-CRA
9-cis RA
9-cis Retinoic Acid
9-cis-RA
9-cis-Retinoic acid
9-cis-Tretinoin
9C-RA
9CRA
A-Acido (Argentina)
A-Vitaminsyre
AC-6824
AC1L9GWO
AC1L9MT9
AC1Q1J2J
AGN 100335
AGN 192013
AGN-192013
AKOS000280845
ALRT 1057
ALRT-1057
AT-RA
ATRA
Aberel
Aberela
Aberela [Norway]
Accutane Roche
Acid, Retinoic
Acid, Vitamin A
Acid, trans-Retinoic
Acnavit
Acnavit [Denmark]
Airol
Aknefug
Aknoten
Alitretinoin
Alitretinoin (USAN)
Alitretinoin [USAN]
Alitretinoinum
Alitretinoína
Alitrétinoïne
Atra-IV
Atragen
Atralin
Avita (TN)
Avita Gel
Avitoin
Avitoin [Norway]
BAL-4079
BAL4079
BB_NC-1005
BIDD:GT0483
BIDD:PXR0081
BML2-E05
BML2-E06
BPBio1_000082
BRN 2057223
BSPBio_000074
BSPBio_001495
BSPBio_001500
Betarretin
C00777
C15493
CCRIS 3294
CCRIS 7098
CHEBI:15367
CHEBI:50648
CHEMBL38
CHEMBL705
CID444795
CID449171
CPD000058245
Cordes VAS [Germany]
Cordes vas
D00094
D014212
D02815
DB00523
DB00755
DB00982
Dermairol
EINECS 206-129-0
EU-0101061
Effederm
Effederm [France]
Epi-aberel
Eudyna
HMS1361K17
HMS1361K22
HMS1568D16
HMS1791K17
HMS1791K22
HMS1921D14
HMS1989K17
HMS1989K22
HMS2089D20
HMS2092N11
HMS502N05
HSDB 2169
HSDB 7186
I04-0008
I14-2351
IDI1_000903
IDI1_033965
IDI1_033970
L000833
LG-100057
 
LGD 100057
LGD 1057
LGD-1057
LMPR01090019
LMPR01090022
LS-1154
LS-1328
Lopac0_001061
Lsotretinoin
MLS000028588
MLS001076515
MLS002207234
MLS002222211
MolPort-000-883-857
MolPort-002-507-281
NCGC00017280-06
NCGC00017280-17
NCGC00021808-04
NCGC00021808-05
NCGC00021808-06
NCGC00021808-07
NCGC00021808-09
NCGC00021808-14
NCGC00021808-15
NCGC00161590-01
NCGC00161590-02
NCGC00161590-03
NCGC00161590-04
NCGC00161590-05
NCGC00161590-06
NCGC00161590-07
NSC 122758
NSC 659772
NSC-122758
NSC-659772
NSC122758
NSC659772
Nexret
PDT-002-002
Panretin
Panretin (TN)
Panretin Gel
Panretyn
Panrexin
Prestwick2_000257
Prestwick3_000257
Prestwick_424
R 2625
R0064
R2625_SIGMA
R4643_SIGMA
REA
Renova
Renova (TN)
Retacnyl
Retin A
Retin A (TN)
Retin-A
Retin-A Micro
Retinoate
Retinoic acid
Retinova
Retionic acid
Retisol-A
Ro 1-5488
Ro-04-4079
S1653_Selleck
SAM002264647
SMR000058245
SPECTRUM1502016
SR-01000000239
SR-01000000239-14
SR-05000013784
SR-05000013784-1
ST057075
STK801887
STOCK1N-38565
Salt, Tretinoin Zinc
Solage
Spectrum5_001746
Spectrum5_001933
Spectrum5_001935
Stieva-A
Stieva-a Forte
TRETINON
Toctino
Tretin M
Tretinoin (TN)
Tretinoin Zinc Salt
Tretinoina
Tretinoine
Tretinoino
Tretinoinum
Tri-Luma
UNII-1UA8E65KDZ
UNII-5688UTC01R
UPCMLD-DP097
UPCMLD-DP097:001
UPCMLD-DP097:002
Vesanoid
Vesanoid (TN)
Vesnaroid
Vitamin A acid
Vitinoin
Zinc Salt, Tretinoin
[3H]Retinoic acid
alitretinoina
alitretinoine
alitretinoinum
all-trans-Tretinoin
b-Retinoic acid
beta-Ra
beta-Retinoic acid
bmse000562
nchembio.106-comp3
nchembio.154-comp2
nchembio861-comp8
trans Retinoic Acid
trans-Retinoic acid
tretinoin
tretinoin liposome
26
Cholecalciferolapproved, nutraceuticalPhase 285167-97-06221, 10883523, 5280795
Synonyms:
()-Vitamin D3
(+)-Vitamin D3
(+)-vitamin D3
(1S,3Z)-3-[(2e)-2-[(1R,3AR,7as)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol
(3S,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(3beta,5Z,7e)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(3beta,Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(5E,7E)-9,10-Secocholesta-5,7,10-trien-3-ol
(5Z,7E)-(3S)-9,10-seco-5,7,10(19)-cholestatrien-3-ol
(5Z,7E)-(3S)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(5Z,7e)-(3S)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
1406-16-2
25(OH)D
3-beta,Z,7E-9,10-Secocholestr-5,7,10(19)-trien-3-ol
47763_SUPELCO
57651-82-8
67-97-0
7-Dehydrocholesterol activated
7-Dehydrocholesterol, Activated
7-Dehydrocholesterol, irradiated
7-Dehydrocholestrol, activated
8024-19-9
8050-67-7
89193_FLUKA
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3-ol
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3beta-ol
9,10-Secocholesta-5(Z),7(E),10(19)-trien-3(.beta.)-ol
9,10-Secocholesta-5,7,10(19)-trien-3-beta-ol
9,10-Secocholesta-5,7,10(19)-trien-3-ol
9,10-Secocholesta-5,7,10-trien-3-ol
AB1002422
AC-11697
AC1L1ECK
AC1L1M23
AC1LU7IZ
AC1NQXLN
AC1NR2UO
AC1NR2UR
AC1NR2UU
AC1NS4AJ
AC1NSHJX
AC1O5EOF
AC1O7GAV
AC1O7GQ3
AC1O8FEU
AC1O8PWJ
AC1OF2GI
AC1OF2GL
AC1OIEW5
AC1OIEWB
ACon1_001997
Activated 7-dehydrocholesterol
Arachitol
BPBio1_000460
BSPBio_000418
BSPBio_002408
Bio-0845
C05443
C1357_SIAL
C27H44O
C9756_SIGMA
C9774_SIAL
CAS-67-97-0
CC
CCRIS 5813
CCRIS 6286
CHEBI:283119
CHEBI:28940
CHEMBL1042
CHEMBL432780
CID10000117
CID10045875
CID10340013
CID10883523
CID10894379
CID11014566
CID11025493
CID11058152
CID11463269
CID1548921
CID2735
CID5280795
CID5283710
CID5283711
CID5283712
CID5353527
CID5363362
CID6221
CID6432644
CID6604201
CID6604662
CID6708595
CID6713938
CID6992015
CID6992016
CID7067439
CID7067440
CID7251172
CID7251174
CID9821465
Calciol
Cholecalciferol
Cholecalciferol (D3)
Cholecalciferol (JP15/USP)
Cholecalciferol D3
Cholecalciferol [USAN:BAN:JAN]
Cholecalciferol, D3
Cholecalciferolum
 
Colecalciferol
Colecalciferol (INN)
Colecalciferolo
Colecalciferolo [DCIT]
Colecalciferolum
Colecalciferolum [INN-Latin]
Colecalcipherol
D00188
D3-Vicotrat
D3-Vigantol
DB00169
Delsterol
Delta-D
Delta-D (TN)
Deparal
Devaron
DivK1c_006276
Duphafral D3 1000
EINECS 200-673-2
EINECS 215-797-2
EPA Pesticide Chemical Code 202901
Ebivit
FeraCol
Granuvit D3
HMS1569E20
HMS2092M12
HSDB 820
I05-0041
Irradiated 7-dehydrocholesterol
KBio1_001220
KBio2_001643
KBio2_004211
KBio2_006779
KBio3_001628
KBioGR_001602
KBioSS_001643
LMST03020001
LMST03020219
LMST03020220
LMST03020221
LS-1570
LS-825
LT00244775
MEGxm0_000458
Micro-dee
MolPort-001-740-051
MolPort-001-785-972
MolPort-003-666-021
MolPort-004-946-964
NCGC00016301-01
NCGC00017328-01
NCGC00091072-01
NCGC00142511-01
NCGC00159331-02
NCGC00159331-04
NCGC00178668-01
NCGC00179565-01
NCGC00179565-02
NEO Dohyfral D3
NSC 375571
NSC-375571
NSC375571
Oleovitamin D3
Prestwick0_000429
Prestwick1_000429
Prestwick2_000429
Prestwick3_000429
Prestwick_63
Provitamine
Provitina
Quintox
Rampage
Ricketon
SMP1_000068
SPBio_001298
SPBio_002357
SR-05000001559
SR-05000001559-3
ST057172
SpecPlus_000180
Spectrum2_001369
Spectrum3_000764
Spectrum4_001201
Spectrum_001163
TNP00266
Trivitan
UNII-1C6V77QF41
UPCMLD-DP152
UPCMLD-DP152:001
VITAMIN D
VITAMIN D3 POWDER
VITAMIN_D3
Vi-De3
Vi-de-3-hydrosol
VidDe-3-hydrosol
Videkhol
Vigantol
Vigorsan
Vitamin D3
Vitamin D3 emulsifiable
Vitinc Dan-Dee-3
ZINC04474460
ZINC04492874
ZINC04492875
ZINC04492876
ZINC04492878
bmse000507
calciol
cholecalciferol
delta-D
vitamin d-3
27
Tretinoinapproved, investigational, nutraceuticalPhase 2220302-79-45538
Synonyms:
(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
.beta.-Retinoic acid
13497-05-7 (hydrochloride salt)
15-Apo-beta-caroten-15-oic acid
187175-63-9
1n4h
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)
302-79-4
5300-03-8
56573-65-0
7005-78-9
9(Z)-Retinoic acid
9-cis-RA
A-Acido (Argentina)
A-Vitaminsyre
A-Vitaminsyre [Denmark]
AC-6824
AC1L9GWO
AC1Q1J2J
AGN 100335
AGN 192013
AKOS000280845
ALRT 1057
AT-RA
ATRA
Aberel
Aberela
Aberela [Norway]
Accutane Roche
Acid A Vit (Belgium, Netherlands)
Acid, Retinoic
Acid, Vitamin A
Acid, all-trans-Retinoic
Acid, beta-all-trans-Retinoic
Acid, trans-Retinoic
Acide retinoique (French) (DSL)
Acide retinoique (french) (dsl)
Acnavit
Acnavit [Denmark]
Airol
Aknefug
Aknoten
Alitretinoin
All Trans Retinoic Acid
All Trans-Retinoic Acid
All-trans Retinoic Acid
Alltrans-retinoic acid
Amnesteem
Atra-IV
Atragen
Atralin
Avita (TN)
Avita Gel
Avitoin
Avitoin [Norway]
BAL4079
BIDD:GT0483
BIDD:PXR0081
BML2-E05
BPBio1_000082
BRN 2057223
BSPBio_000074
BSPBio_001500
Betarretin
C00777
CCRIS 3294
CCRIS 7098
CHEBI:15367
CHEMBL38
CID444795
CPD000058245
Claravis
Cordes VAS [Germany]
Cordes vas
D00094
D014212
DB00523
DB00755
DB00982
Dermairol
EINECS 206-129-0
EU-0101061
Effederm
Effederm [France]
Epi-aberel
Eudyna
HMS1361K22
HMS1568D16
HMS1791K22
HMS1921D14
HMS1989K22
HMS2089D20
HMS2092N11
HMS502N05
HSDB 2169
HSDB 7186
I04-0008
I14-2351
IDI1_000903
IDI1_033970
Isotretinoin Retinoic acid
L000833
LGD 100057
LMPR01090019
LS-1154
Lopac0_001061
Lsotretinoin
MLS000028588
MLS001076515
MLS002207234
MLS002222211
MolPort-000-883-857
NCGC00017280-06
NCGC00017280-17
NCGC00021808-04
 
NCGC00021808-05
NCGC00021808-06
NCGC00021808-07
NCGC00021808-09
NCGC00021808-14
NCGC00021808-15
NSC 122758
NSC-122758
NSC122758
Nexret
PDT-002-002
Panretin Gel
Panretyn
Potassium Salt, Tretinoin
Prestwick2_000257
Prestwick3_000257
Prestwick_424
R 2625
R0064
R2625_SIGMA
REA
RETINOIC ACID, ALL TRANS
RETINOIC acid
Renova
Renova (TN)
Retacnyl
Retin A
Retin A (TN)
Retin-A
Retin-A Micro
Retin-a
Retinoate
Retinoic acid
Retinoic acid, all-trans- (8CI)
Retinova
Retionic Acid
Retionic acid
Retisol-A
Retisol-a
Ro 1-5488
S1653_Selleck
SAM002264647
SMR000058245
SPECTRUM1502016
SR-01000000239
SR-01000000239-14
ST057075
Salt, Tretinoin Potassium
Salt, Tretinoin Sodium
Salt, Tretinoin Zinc
Sodium Salt, Tretinoin
Solage
Sotret
Spectrum5_001746
Spectrum5_001933
Stieva-A
Stieva-a
Stieva-a Forte
TRETINON
Tretin M
Tretin m
Tretinoin
Tretinoin (JAN/USP/INN)
Tretinoin (TN)
Tretinoin 0.1% cream or placebo
Tretinoin Potassium Salt
Tretinoin Sodium Salt
Tretinoin Zinc Salt
Tretinoin [USAN:INN:BAN]
Tretinoin/All-Trans Retinoic Acid
Tretinoina
Tretinoina [INN-Spanish]
Tretinoine
Tretinoine (french) (einecs)
Tretinoine [INN-French]
Tretinoino
Tretinoino [INN-Spanish]
Tretinoinum
Tretinoinum [INN-Latin]
Tri-Luma
Trétinoïne
UNII-1UA8E65KDZ
UNII-5688UTC01R
UPCMLD-DP097
Vesanoid
Vesanoid (TN)
Vesanoid, Airol, Renova, Atralin, Retin-A, Avita, Tretinoin
Vesnaroid
Vitamin A acid
Vitinoin
WLN: L6UTJ A1 B1U1Y1 & U2U1Y1 & U1VQ C1 C1
WLN: L6UTJ A1 B1U1Y1&U2U1Y1&U1VQ C1 C1
Zinc Salt, Tretinoin
[3H]Retinoic acid
all trans-Retinoic acid
all-(E)-Retinoic acid
all-(e)-Retinoic acid
all-trans-Retinoic acid
all-trans-Tretinoin
all-trans-Vitamin A acid
all-trans-Vitamin A1 acid
all-trans-Vitamin a acid
all-trans-Vitamin a1 acid
all-trans-b-Retinoic acid
all-trans-beta-Retinoic acid
b-Retinoic acid
beta all trans Retinoic Acid
beta-Ra
beta-Retinoic Acid
beta-Retinoic acid
beta-all-trans-Retinoic acid
bmse000562
nchembio.154-comp2
trans Retinoic Acid
trans-Retinoic acid
tretinoin
tretinoin liposome
tretinoine (French) (EINECS)
28
Ergocalciferolapproved, nutraceuticalPhase 2123250-14-65280793
Synonyms:
'Ergosterol irradiated'
(+)-Vitamin D2
(3-beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10,(19),22-tetraen-3-ol
(3S,5Z,7E,14xi,17alpha,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3beta,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
(5E,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
22-Tetraen 3beta 9,10,Secoergosta-5,7,10(19)-ol
31316-19-5
4-Methylene-3-[2-[tetrahydro-7a-methyl-1-(1,4,5-trimethyl-2-hexenyl)-4(3aH)-indanylidene]ethylidene]-Cyclohexanol
47768_SUPELCO
50-14-6
7489-18-1
7E677DC1-E1C4-4FC5-8F4A-BCE1857F7E87
8017-28-5
9,10,Secoergosta-5,7,10(19),22-tetraen 3.beta.-ol
9,10-Seco(5Z,7E,22E)-5,7,10(19),22-ergostatetraen-3-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3-beta-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3b-ol
95220_FLUKA
95220_SIGMA
AC-1355
AC1L1FIE
AC1NQXLH
AC1NS4DE
AC1NS9GI
AC1NSSVD
AC1NWAM3
AC1O5EDK
AC1O6WAM
ACon1_002187
Activated ergosterol
BPBio1_000418
BSPBio_000380
BSPBio_001974
Buco-D
C05441
C28H44O
CALCIFEROL IN A GELATIN MATRIX
CALCIFEROL, U.S.P.
CHEBI:28934
CHEMBL1536
CID11003810
CID3249
CID5280793
CID5315257
CID5353610
CID5356615
CID5702050
CID6432478
CID6536972
Calciferol
Calciferol (TN)
Calciferol (vitamin D2)
Calciferolum
Calciferon 2
Condacaps
Condocaps
Condol
Crtron
Crystallina
D-Arthin
D-Tracetten
D00187
DB00153
Daral
Davitamon D
Davitin
De-rat concentrate
Decaps
Dee-Osterol
Dee-Ron
Dee-Ronal
Dee-Roual
Deltalin
Deratol
Detalup
Diactol
Divit urto
Doral
Drisdol
Drisdol (TN)
E5750_SIGMA
EINECS 200-014-9
Ercalciol
Ergocalciferol
Ergocalciferol (D2)
Ergocalciferol (JP15/USP)
Ergocalciferol [INN:BAN:JAN]
Ergocalciferol oil
Ergocalciferol: Vitamin D
 
Ergocalciferolo
Ergocalciferolo [DCIT]
Ergocalciferols
Ergocalciferolum
Ergocalciferolum [INN-Latin]
Ergorone
Ergosterol activated
Ergosterol irradiated
Ergosterol, irradiated
Ertron
Fortodyl
Geltabs
Geltabs Vitamin D
HMS1920K20
HMS2091B19
HMS502I07
HSDB 819
Haliver
Hi-Deratol
Hyperkil
I05-0022
IDI1_000805
Infron
Irradiated ergosta-5,7,22-trien-3-beta-ol
Irradiated ergosta-5,7,22-trien-3.beta.-ol
Irradiated ergosta-5,7,22-trien-3beta-ol
Irradiated ergosterol
LMST03010001
LMST03010014
LS-3228
MEGxm0_000466
MLS001332467
MLS001332468
Metadee
Mina D2
MolPort-001-740-057
MolPort-001-793-930
MolPort-002-526-645
MolPort-003-666-178
MolPort-006-822-629
Mulsiferol
Mykostin
NCGC00142497-01
NCGC00179579-01
NCGC00179579-02
NSC 62792
NSC62792
Novovitamin-D
Oleovitamin D
Oleovitamin D, Synthetic
Oleovitamin D2
Osteil
Ostelin
Prestwick3_000420
Prestwick_554
Radiostol
Radstein
Radsterin
Rodine C
Rodinec
SMR000857106
SPECTRUM1500276
ST057150
STOCK1N-53397
Shock-ferol
Shock-ferol sterogyl
Sorex C.R
Sorex C.R.
Spectrum5_000666
Sterogyl
Synthetic Vitamin D
UNII-VS041H42XC
Uvesterol D
Uvesterol-D
VITAMIN D2
VITAMIN D2 WATER DISPERSABLE U.S.P.
VITAMIN_D2
Vigantol
Vio D
Vio-D
Viostdrol
Viosterol
Viosterol in Oil
Vitamin D2
Vitamin- D2
Vitamin-?D2
Vitamina D2
Vitavel-D
WLN: L56 FYTJ A1 BY1&1U1Y1&Y1&1 FU2U- BL6YYTJ AU1 DQ
ZINC04474571
ZINC04629876
beta-Ol
bmse000510
component of Geltabs Vitamin D
delta-Arthin
delta-Tracetten
ergocalciferol
vitamin d-2
29Anti-Inflammatory Agents, Non-SteroidalPhase 2, Phase 14295
30Gastrointestinal AgentsPhase 28109
31Anti-Inflammatory AgentsPhase 2, Phase 110355
32Analgesics, Non-NarcoticPhase 2, Phase 16260
33AnalgesicsPhase 2, Phase 111287
34Immunosuppressive AgentsPhase 2, Phase 112770
35Peripheral Nervous System AgentsPhase 2, Phase 122776
36Calcineurin InhibitorsPhase 21597
37VitaminsPhase 25095
38vitamin dPhase 21653
39MicronutrientsPhase 25802
40Bone Density Conservation AgentsPhase 23266
41Trace ElementsPhase 25802
42AntibodiesPhase 2, Phase 1, Early Phase 16045
43Antibodies, MonoclonalPhase 2, Phase 13795
44Phosphodiesterase 5 InhibitorsPhase 1, Phase 2571
45Phosphodiesterase InhibitorsPhase 1, Phase 21254
46ImmunoglobulinsPhase 2, Phase 1, Early Phase 16045
47Angiogenesis InhibitorsPhase 24143
48Anti-Bacterial AgentsPhase 210884
49NorfluranePhase 23
50Angiogenesis Modulating AgentsPhase 24072

Interventional clinical trials:

(show top 50)    (show all 66)
idNameStatusNCT IDPhase
1Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active DiseaseActive, not recruitingNCT01753401Phase 4
2Trial to Study the Effects of Supplementary Omega-3 on Serum C-Reactive Protein LevelsTerminatedNCT00578578Phase 4
3Multicenter Study Assessing the Efficacy & Safety of Hydroxychloroquine Sulfate in Patients With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus With Active Lupus Erythematosus Specific Skin LesionCompletedNCT01551069Phase 3
4Sunscreen RV 2457C in Photoinduced CLECompletedNCT00470912Phase 3
5The Safety and Efficacy of Etanercept (Enbrel®) for the Treatment of Discoid Lupus ErythematosusUnknown statusNCT00797784Phase 2
6Treatment of Cutaneous Lupus Erythematosus (CLE) With the 595 nm Flashlamp Pulsed Dye LaserCompletedNCT00523588Phase 2
7Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus ErythematosusCompletedNCT01294774Phase 2
8Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE)CompletedNCT00317681Phase 2
9To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus ErythematosusCompletedNCT01300208Phase 2
10Efficacy and Safety of Fumaric Acid Esters (Fumaderm®) in the Treatment of Patients With Cutaneous Lupus ErythematosusCompletedNCT01352988Phase 2
11Safety Study of Clinical and Immune Effects of Phosphodiesterase 4 (PDE-4) Inhibitor in Cutaneous Lupus PatientsCompletedNCT00708916Phase 1, Phase 2
12Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) LesionsCompletedNCT01597050Phase 2
13A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus ErythematosusCompletedNCT01283139Phase 2
14Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) LesionsCompletedNCT00625521Phase 2
15Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions (2)CompletedNCT00625157Phase 2
16A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus ErythematosusCompletedNCT00001680Phase 2
17Study to Evaluate BIIB059 in CLE With or Without SLERecruitingNCT02847598Phase 2
18A Phase 2a of RSLV-132 in Subjects With Systemic Lupus Erythematosus (SLE)RecruitingNCT02660944Phase 2
19Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus ErythematosusRecruitingNCT02656082Phase 2
20TAB08 in Patients With Systemic Lupus Erythematosus (SLE), Not Adequately Controlled With Current TreatmentRecruitingNCT02711813Phase 2
21Phase Ib Study of SC Milatuzumab in SLERecruitingNCT01845740Phase 1, Phase 2
22A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus.RecruitingNCT02185040Phase 2
23A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus ErythematosusRecruitingNCT02437890Phase 2
24Safety and Efficacy Study of a Biologic to Treat Systemic Lupus ErythematosusRecruitingNCT02265744Phase 2
25Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus NephritisRecruitingNCT02770170Phase 2
26Belimumab for the Treatment of Diffuse Cutaneous Systemic SclerosisActive, not recruitingNCT01670565Phase 2
27A Phase II Study of M2951 in Systemic Lupus Erythematosus (SLE)Not yet recruitingNCT02975336Phase 2
28Efficacy and Safety of Oral Alitretinoin (Toctino®) in the Treatment of Patients With Cutaneous Lupus ErythematosusTerminatedNCT01407679Phase 2
29Vitamin D Status, Disease Specific and Quality of Life Outcomes in Patients With Cutaneous LupusTerminatedNCT01498406Phase 2
30A Research Study to Assess if CC-930 is Safe in Treating Subjects With Discoid Lupus ErythematosusTerminatedNCT01466725Phase 2
31Discoid Lupus Erythematosus of the Scalp and a Trial of Biologic Therapy With RaptivaTerminatedNCT00308204Phase 2
32A Study of the Safety and Pharmacokinetics of CNTO 136 in Patients With Cutaneous Lupus Erythematosus and Systemic Lupus ErythematosusCompletedNCT01702740Phase 1
33Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of GSK2646264 in Cutaneous Lupus Erythematosus PatientsRecruitingNCT02927457Phase 1
34Autologous Polyclonal Tregs for LupusRecruitingNCT02428309Phase 1
35A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus ErythematosusTerminatedNCT01470313Phase 1
36Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus ErythematosusTerminatedNCT01389895Phase 1
37Safety Study of AMG 811 in Subjects With Discoid Lupus ErythematosusTerminatedNCT01164917Phase 1
38Nonmyeloablative Allo Stem Cell Transplant for Severe Autoimmune DiseasesTerminatedNCT00849745Phase 1
39Cutaneous Lupus Erythematosus and ElidelUnknown statusNCT00222183
40Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune DiseasesUnknown statusNCT00006055
41IVIg Efficacy Study to Treat Cutaneous Lupus ErythematosusCompletedNCT01841619Early Phase 1
42Effectiveness of a Knowledge-based Intervention for Patients With Cutaneous Lupus ErythematosusCompletedNCT01629784
43Evaluation of Lenalidomide (REVLIMID®) to Treat Subjects With Cutaneous Lupus Erythematosus (CLE)CompletedNCT00633945
44Sunscreens in Patients With Cutaneous Lupus Erythematosus(CLE)CompletedNCT01146444
45A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy VolunteersCompletedNCT02034344Early Phase 1
46Interdisciplinary Study Group of Lupus Erythematosus (ISGLE)CompletedNCT00420173
47A Non-drug Study Profiling Cutaneous LupusCompletedNCT01923415Early Phase 1
48Pilot Tape Harvesting StudyCompletedNCT02125695
49Comparing the Therapeutic Efficacy of Pimecrolimus Cream With Betamethasone Cream for Discoid Lupus ErythematosusCompletedNCT00608673
50A Pooled Analysis of the HGS1006-C1056 (BLISS-52) and HGS1006-C1057 (BLISS-76) StudiesCompletedNCT01858792

Search NIH Clinical Center for Cutaneous Lupus Erythematosus

Genetic Tests for Cutaneous Lupus Erythematosus

About this section

Anatomical Context for Cutaneous Lupus Erythematosus

About this section

MalaCards organs/tissues related to Cutaneous Lupus Erythematosus:

36
Skin, T cells, Neutrophil, Testes, Bone, Breast, Lung

Publications for Cutaneous Lupus Erythematosus

About this section

Articles related to Cutaneous Lupus Erythematosus:

(show top 50)    (show all 708)
idTitleAuthorsYear
1
A Cutaneous Lupus Erythematosus-Like Eruption Induced by Hydroxyurea. (27813209)
2017
2
Rowell's Syndrome or subacute cutaneous lupus erythematosus? (27978611)
2017
3
Voriconazole-Induced Subacute Cutaneous Lupus Erythematosus in an Adult With Aspergillosis. (28031137)
2016
4
Immunomodulation in cutaneous lupus erythematosus subsets. (27492812)
2016
5
Cutaneous Lupus Erythematosus in Children: Experience from a Tertiary Care Pediatric Dermatology Clinic. (27001318)
2016
6
Using the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria to determine the diagnosis of systemic lupus erythematosus (SLE) in patients with subacute cutaneous lupus erythematosus (SCLE). (26897388)
2016
7
Advances in the treatment of cutaneous lupus erythematosus. (27252259)
2016
8
Lenalidomide for refractory chronic and subacute cutaneous lupus erythematosus: 16 patients. (27185425)
2016
9
Cutaneous lupus erythematosus is strongly associated with psychiatric disease. (27206359)
2016
10
S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV). (27859683)
2016
11
Cutaneous Lupus Erythematosus: An Update on Pathogenesis, Diagnosis and Treatment. (26872954)
2016
12
Ziprasidone-induced sub acute cutaneous lupus erythematosus. (27838681)
2016
13
Cancer risk in cutaneous lupus erythematosus: a population-based cohort study. (27520797)
2016
14
Fumaric acid ester treatment in cutaneous lupus erythematosus (CLE): a prospective, open-label, phase II pilot study. (27147621)
2016
15
Therapeutic options for cutaneous lupus erythematosus: recent advances and future prospects. (27249209)
2016
16
Toxic Epidermal Necrolysis Like Reaction due to Low-dose Methotrexate in a Case of Cutaneous Lupus Erythematosus: A Rare Occurrence. (26955111)
2016
17
The effect of increasing the dose of hydroxychloroquine (HCQ) in patients with refractory cutaneous lupus erythematosus (CLE): An open-label prospective pilot study. (26850655)
2016
18
Spleen tyrosine kinase (SYK) is a potential target for the treatment of cutaneous lupus erythematosus patients. (26910509)
2016
19
Effects of hydroxychloroquine on cutaneous lupus erythematosus: A multi-center double-blind randomized parallel-group trial. (27992698)
2016
20
Lenalidomide treatment of cutaneous lupus erythematosus: the Mayo Clinic experience. (26873674)
2016
21
Ethnic differences in the epidemiology of cutaneous lupus erythematosus in New Zealand. (27235700)
2016
22
Treatment of cutaneous lupus erythematosus: current practice variations. (26821963)
2016
23
The incidence of herpes zoster in cutaneous lupus erythematosus (CLE), dermatomyositis (DM), pemphigus vulgaris (PV), and bullous pemphigoid (BP). (27317514)
2016
24
The role of Syk in cutaneous lupus erythematosus. (26999068)
2016
25
Cutaneous lupus erythematosus of elbows: A distinct entity? (26952182)
2016
26
Drug-induced cutaneous lupus erythematosus: 88 new cases. (27799135)
2016
27
Cutaneous lupus erythematosus: updates on pathogenesis and associations with systemic lupus. (27270345)
2016
28
Drug-Induced Subacute Cutaneous Lupus Erythematosus Associated with Proton Pump Inhibitors. (27398293)
2016
29
Proton Pump Inhibitor-Associated Subacute Cutaneous Lupus Erythematosus in a Patient With Granulomatosis With Polyangiitis. (27870768)
2016
30
Subacute cutaneous lupus erythematosus inducing unilateral sensorimotor neuropathy. (27888319)
2016
31
Anastrozole-induced subacute cutaneous lupus erythematosus. (27622265)
2016
32
Gemcitabine-Induced Subacute Cutaneous Lupus Erythematosus: A Case Report. (26928175)
2016
33
Cutaneous sarcoidosis masquerading as chronic cutaneous lupus erythematosus - case report. (27646659)
2016
34
Rare Occurrence of Drug Induced Subacute Cutaneous Lupus Erythematosus with Leflunomide Therapy. (27891379)
2016
35
A cross-sectional study of untreated depression and anxiety in cutaneous lupus erythematosus and dermatomyositis. (26775780)
2016
36
Subacute cutaneous lupus erythematosus. (27286780)
2016
37
Mycophenolate Mofetil in Refractory Cutaneous Lupus Erythematosus: No Definitive Evidence. (27587015)
2016
38
A Systematic Review of Patient-Reported Outcomes (PROs) in Patients with Cutaneous Lupus Erythematosus (CLE). (27416958)
2016
39
Cutaneous lupus erythematosus induced by golimumab therapy. (27458030)
2016
40
First case of paraneoplastic subacute cutaneous lupus erythematosus associated with colon cancer. (27836354)
2016
41
Vitamin D levels in 87 Asian patients with cutaneous lupus erythematosus: a case-control study. (27480455)
2016
42
Risk of Cerebrovascular Accidents and Ischemic Heart Disease in Cutaneous Lupus Erythematosus: A Population-based Cohort Study. (27015109)
2016
43
Apoptosis of keratinocytes and serum DNase I activity in patients with cutaneous lupus erythematosus: relationship with clinical and immunoserological parameters. (27557471)
2016
44
Primary cicatricial alopecia: Lymphocytic primary cicatricial alopecias, including chronic cutaneous lupus erythematosus, lichen planopilaris, frontal fibrosing alopecia, and Graham-Little syndrome. (27846944)
2016
45
Methimazole-induced chronic cutaneous lupus erythematosus. (27519167)
2016
46
Beside to bench: JAK-inhibitor ruxolitinib inhibits the expression of cytokines characteristic of cutaneous lupus erythematosus. (27892610)
2016
47
Immunogenetics of cutaneous lupus erythematosus. (27386968)
2016
48
Bilateral periorbital swelling as the initial presentation of cutaneous lupus erythematosus. (27051834)
2016
49
Clinical characteristics of cutaneous lupus erythematosus. (26985173)
2016
50
Pregnancy and contraception in systemic and cutaneous lupus erythematosus. (27129743)
2016

Variations for Cutaneous Lupus Erythematosus

About this section

Expression for genes affiliated with Cutaneous Lupus Erythematosus

About this section
Search GEO for disease gene expression data for Cutaneous Lupus Erythematosus.

Pathways for genes affiliated with Cutaneous Lupus Erythematosus

About this section

Pathways related to Cutaneous Lupus Erythematosus according to GeneCards Suite gene sharing:

(show all 18)
idSuper pathwaysScoreTop Affiliating Genes
19.5IL18, TNF
29.4ICAM1, TNF
39.4ICAM1, TNF
49.3CXCR3, IL18, TNF
5
Show member pathways
9.2IL18, MX1, TNF
69.1ICAM1, SELE, TNF
79.1ICAM1, SELE, TNF
89.1CD40LG, IL18, TNF
99.1CD40LG, ICAM1, SELE
109.0CD40LG, ICAM1, TNF
119.0CD40LG, ICAM1, TNF
128.9ICAM1, IL18, TNF
138.7EEA1, IL18, TNF
148.6ICAM1, IL18, SELE, TNF
15
Show member pathways
8.6ICAM1, IL18, MX1, TNF
16
Show member pathways
8.5CD40LG, ICAM1, IL18, TNF
178.1CD40LG, ICAM1, IL18, SELE, TNF
18
Show member pathways
6.7CD40LG, EEA1, ICAM1, IL18, MX1, TNF

GO Terms for genes affiliated with Cutaneous Lupus Erythematosus

About this section

Cellular components related to Cutaneous Lupus Erythematosus according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1external side of plasma membraneGO:00098978.7CD40LG, CXCR3, ICAM1, TNF

Biological processes related to Cutaneous Lupus Erythematosus according to GeneCards Suite gene sharing:

(show all 8)
idNameGO IDScoreTop Affiliating Genes
1leukocyte tethering or rollingGO:005090110.3SELE, TNF
2negative regulation of myoblast differentiationGO:004566210.1IL18, TNF
3positive regulation of NF-kappaB import into nucleusGO:004234610.1IL18, TNF
4leukocyte migrationGO:00509009.7ICAM1, SELE, TNF
5leukocyte cell-cell adhesionGO:00071599.7CD40LG, ICAM1, SELE
6regulation of immunoglobulin secretionGO:00510239.6CD40LG, TNF
7inflammatory responseGO:00069549.1CD40LG, CXCR3, IL18, SELE, TNF
8positive regulation of NF-kappaB transcription factor activityGO:00510929.1CD40LG, ICAM1, TNF

Molecular functions related to Cutaneous Lupus Erythematosus according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1tumor necrosis factor receptor bindingGO:00051649.6CD40LG, TNF
2cytokine activityGO:00051259.5CD40LG, IL18, TNF

Sources for Cutaneous Lupus Erythematosus

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet